S0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma
Stopped lack of accrual
Conditions
- Multiple Myeloma
- Plasma Cell Myeloma
Interventions
- DRUG: bortezomib
- DRUG: cisplatin
- DRUG: cyclophosphamide
- DRUG: dexamethasone
- DRUG: doxorubicin hydrochloride
- DRUG: etoposide
- DRUG: lenalidomide
- DRUG: melphalan
- DRUG: thalidomide
- GENETIC: gene expression analysis
- GENETIC: microarray analysis
- OTHER: laboratory biomarker analysis
- PROCEDURE: autologous-autologous tandem hematopoietic stem cell transplantation
Sponsor
SWOG Cancer Research Network
Collaborators